Literature DB >> 7991744

The psychological impact of motor neurone disease.

K E Hogg1, L H Goldstein, P N Leigh.   

Abstract

Self-report measures were completed by 59 individuals with motor neurone disease (MND) in order to assess whether: (a) MND affects patients' psychological well-being and quality of life; (b) if greater affective disorder is associated with greater physical disability; (c) whether accepting the illness and ways of coping have an impact on psychological distress, and (d) if beliefs over control of their health shift as the disease progresses. Results indicated that the effects of MND on everyday functioning accounted for incidence of depression and low self-esteem. Acceptance of illness was related to severity of symptoms and was a significant factor irrespective of level of physical symptomatology. Ways of coping with the illness did not relate in any significant way to severity of symptoms. Mild physical impairments were associated with an 'internal' view of control over health.

Entities:  

Mesh:

Year:  1994        PMID: 7991744     DOI: 10.1017/s003329170002777x

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  21 in total

1.  Psychopathological features and suicidal ideation in amyotrophic lateral sclerosis patients.

Authors:  Arianna Palmieri; Gianni Sorarù; Elisa Albertini; Carlo Semenza; Francesca Vottero-Ris; Carla D'Ascenzo; Giorgia Querin; Alessandro Zennaro; Elena Pegoraro; Corrado Angelini
Journal:  Neurol Sci       Date:  2010-06-03       Impact factor: 3.307

2.  Assessing individual quality of life in amyotrophic lateral sclerosis.

Authors:  S Clarke; A Hickey; C O'Boyle; O Hardiman
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

3.  A cross sectional study on determinants of quality of life in ALS.

Authors:  A Chiò; A Gauthier; A Montuschi; A Calvo; N Di Vito; P Ghiglione; R Mutani
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

4.  The impact of the financial costs of multiple sclerosis on quality of life.

Authors:  Margaret A De Judicibus; Marita P McCabe
Journal:  Int J Behav Med       Date:  2007

5.  Depression in amyotrophic lateral sclerosis.

Authors:  Elin Roos; Daniela Mariosa; Caroline Ingre; Cecilia Lundholm; Karin Wirdefeldt; Per M Roos; Fang Fang
Journal:  Neurology       Date:  2016-04-22       Impact factor: 9.910

Review 6.  Economic Studies in Motor Neurone Disease: A Systematic Methodological Review.

Authors:  Alan Moore; Carolyn A Young; Dyfrig A Hughes
Journal:  Pharmacoeconomics       Date:  2017-04       Impact factor: 4.981

7.  Prevalence of depressive disorders and change over time in late-stage ALS.

Authors:  J G Rabkin; S M Albert; M L Del Bene; I O'Sullivan; T Tider; L P Rowland; H Mitsumoto
Journal:  Neurology       Date:  2005-07-12       Impact factor: 9.910

Review 8.  Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management.

Authors:  Anja Kurt; Femke Nijboer; Tamara Matuz; Andrea Kübler
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 9.  Sleep in patients with amyotrophic lateral sclerosis.

Authors:  J Hetta; I Jansson
Journal:  J Neurol       Date:  1997-04       Impact factor: 4.849

10.  Depression and quality of life in patients with amyotrophic lateral sclerosis.

Authors:  Dorothée Lulé; Sonja Häcker; Albert Ludolph; Niels Birbaumer; Andrea Kübler
Journal:  Dtsch Arztebl Int       Date:  2008-06-06       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.